Brendan Smith
Stock Analyst at TD Cowen
(1.72)
# 3,067
Out of 5,127 analysts
16
Total ratings
37.5%
Success rate
4.31%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $14 → $12 | $9.38 | +27.93% | 2 | Jan 8, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $32 → $43 | $35.60 | +20.79% | 1 | Jan 8, 2026 | |
| SLP Simulations Plus | Maintains: Hold | $16 → $19 | $19.07 | -0.37% | 2 | Jan 8, 2026 | |
| SDGR Schrödinger | Maintains: Buy | $33 → $24 | $18.36 | +30.72% | 1 | Jan 8, 2026 | |
| CTKB Cytek Biosciences | Maintains: Buy | $4 → $5 | $5.48 | -8.68% | 1 | Jan 8, 2026 | |
| AZTA Azenta | Maintains: Hold | $35 → $39 | $38.40 | +1.56% | 1 | Jan 8, 2026 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $79 → $90 | $72.55 | +24.05% | 3 | Jan 8, 2026 | |
| NVAX Novavax | Maintains: Hold | $8 → $7 | $7.31 | -4.24% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $275.36 | +27.11% | 1 | Oct 29, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $64.92 | - | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $17.09 | - | 1 | Dec 5, 2022 |
Ginkgo Bioworks Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $14 → $12
Current: $9.38
Upside: +27.93%
Twist Bioscience
Jan 8, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $35.60
Upside: +20.79%
Simulations Plus
Jan 8, 2026
Maintains: Hold
Price Target: $16 → $19
Current: $19.07
Upside: -0.37%
Schrödinger
Jan 8, 2026
Maintains: Buy
Price Target: $33 → $24
Current: $18.36
Upside: +30.72%
Cytek Biosciences
Jan 8, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $5.48
Upside: -8.68%
Azenta
Jan 8, 2026
Maintains: Hold
Price Target: $35 → $39
Current: $38.40
Upside: +1.56%
Halozyme Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $79 → $90
Current: $72.55
Upside: +24.05%
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $7.31
Upside: -4.24%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $275.36
Upside: +27.11%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $64.92
Upside: -
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $17.09
Upside: -